U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C15H20Cl2N2O
Molecular Weight 315.238
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CLIBUCAINE

SMILES

CC(CC(=O)NC1=CC=C(Cl)C=C1Cl)N2CCCCC2

InChI

InChIKey=GDDYCOSWVJRUHM-UHFFFAOYSA-N
InChI=1S/C15H20Cl2N2O/c1-11(19-7-3-2-4-8-19)9-15(20)18-14-6-5-12(16)10-13(14)17/h5-6,10-11H,2-4,7-9H2,1H3,(H,18,20)

HIDE SMILES / InChI
Molecular Formula C15H20Cl2N2O
Molecular Weight 315.238
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Description

Clibucaine is a piperidine derivative possessing local anesthetic properties and used in the clinic as a local anesthetic in the 1980s.

Approval Year

Unknown
149124
Substance Class Chemical
Created
by admin
on Mon Mar 31 18:18:40 GMT 2025
Edited
by admin
on Mon Mar 31 18:18:40 GMT 2025
Record UNII
NB2ZOX88RR
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CLIBUCAINE
INN   WHO-DD  
INN  
Official Name English
Clibucaine [WHO-DD]
Preferred Name English
clibucaine [INN]
Common Name English
2',4'-DICHLORO-.BETA.-PIPERIDINOBUTYRANILIDE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C245
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
Code System Code Type Description
SMS_ID
100000080216
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
PRIMARY
INN
1661
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
PRIMARY
EPA CompTox
DTXSID80864581
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
PRIMARY
PUBCHEM
65613
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
PRIMARY
EVMPD
SUB06657MIG
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
PRIMARY
CAS
15302-10-0
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
PRIMARY
FDA UNII
NB2ZOX88RR
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
PRIMARY
NCI_THESAURUS
C77321
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
PRIMARY
ChEMBL
CHEMBL2104620
Created by admin on Mon Mar 31 18:18:40 GMT 2025 , Edited by admin on Mon Mar 31 18:18:40 GMT 2025
PRIMARY
Related Record Type Details
Structure of CLIBUCAINE, (R)-
ENANTIOMER -> RACEMATE
Structure of CLIBUCAINE, (S)-
ENANTIOMER -> RACEMATE
Related Record Type Details
Structure of CLIBUCAINE
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966